Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multinational Observational Uncontrolled Open Programme "The Use of TRIple Fixed-dose COmbination in the Treatment of arteriaL Hypertension: Opportunity for Effective BP Control With cOmbined Antihypertensive Therapy"

Next Previous
Trial Profile

Multinational Observational Uncontrolled Open Programme "The Use of TRIple Fixed-dose COmbination in the Treatment of arteriaL Hypertension: Opportunity for Effective BP Control With cOmbined Antihypertensive Therapy"

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Aug 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Amlodipine/indapamide/perindopril (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms TRICOLOR

    • Most Recent Events

    • 20 Jun 2022 Results of post-hoc analysis presented at the 31st European meeting on hypertension and cardiovascular protection.
    • 20 Jun 2022 Results of post-hoc analysis assessing antihypertensive effectiveness, and treatment adherence in HTN patients depending on age presented at the 31st European meeting on hypertension and cardiovascular protection
    • 14 Apr 2021 Primary endpoint (The Mean Diastolic BP Changes (mm Hg) at the Visit 4 vs Baseline.) has been met as per results presented at the Joint Meeting of the European Society of Hypertension and International Society of Hypertension
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top